Upfront palliative resection of primary tumor versus no resection in patients with synchronous metastatic colorectal cancer: The randomized phase 3 CAIRO4 study of the Dutch Colorectal Cancer Group (DCCG).

被引:0
|
作者
Koopman, Miriam
van der Kruijssen, Dave Eduard Wilhelm
Elias, Sjoerd G.
de Ven, Peter M. van
Mol, Linda
Punt, Cornelis J. A.
Tanis, Pieter J.
Nielsen, Jesper Dan
Yilmaz, Mette K.
Loosveld, Olaf
van der Schelling, George P.
Wasowicz-Kemps, Dareczka
Van Riel, Johanna M. G. H.
Verseveld, Mareille
Hamberg, Paul
Jakobsen, Henrik Loft
Fromm, Anna-Lene
van Westreenen, Henderik L.
de Groot, Jan Willem
de Wilt, Johannes H. W.
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] Netherlands Comprehens Canc Org IKNL, Clin Res Dept, Nijmegen, Netherlands
[4] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[5] Erasmus MC, Rotterdam, Netherlands
[6] Univ Amsterdam, Canc Ctr Amsterdam, Med Ctr, Rotterdam, Netherlands
[7] Univ Amsterdam, Canc Ctr Amsterdam, Med Ctr, Amsterdam, Netherlands
[8] Aalborg Univ Hosp, Dept Surg, Aalborg, Denmark
[9] Aalborg Univ Hosp, Aalborg, Denmark
[10] Amphia Hosp, Breda, Netherlands
[11] Elisabeth TweeSteden Hosp, Tilburg, Netherlands
[12] Elisabeth Tweesteden Hosp, Tilburg, Netherlands
[13] Franciscus Gasthuis & Vlietland, Rotterdam, Netherlands
[14] Franciscus Gasthuis & Vlietland, Dept Med Oncol, Rotterdam, Netherlands
[15] Herlev & Gentofte Univ Hosp, Herlev, Denmark
[16] Herlev & Gentofte Hosp, Herlev, Denmark
[17] Isala Oncol Ctr, Zwolle, Netherlands
[18] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3517
引用
收藏
页数:1
相关论文
共 50 条
  • [21] RANDOMIZED PHASE III STUDY OF CAPECITABINE, OXALIPLATIN AND BEVACIZUMAB WITH OR WITHOUT CETUXIMAB IN ADVANCED COLORECTAL CANCER (ACC), THE CAIRO2 STUDY OF THE DUTCH COLORECTAL CANCER GROUP (DCCG)
    Tol, J.
    Koopman, M.
    Antonini, N. F.
    Sinnige, H.
    Valster, F. A. A.
    Braun, J. J.
    ten Tije, A. J.
    Mol, L.
    van Krieken, J. H. J. M.
    Punt, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 128 - 128
  • [22] THE CAIRO4 STUDY: THE ROLE OF SURGERY OF THE PRIMARY TUMOUR WITH FEW OR ABSENT SYMPTOMS IN PATIENTS WITH SYNCHRONOUS UNRESECTABLE METASTASES OF COLORECTAL CANCER: A RANDOMIZED PHASE III STUDY
    Jorine, 't Lam-Boer
    Linda, Mol
    Cornelis, Verhoef
    Ton, de Haan
    Cornelis, Punt
    Johannes, De Wilt
    Miriam, Koopman
    ANNALS OF ONCOLOGY, 2014, 25 : 94 - 94
  • [23] Randomized phase III study of capecitabine, oxaliplatin, and bevacizumab with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG)
    Punt, C. J.
    Tol, J.
    Rodenburg, C. J.
    Cats, A.
    Creemers, G.
    Schrama, J. G.
    Erdkamp, F. L.
    Vos, A.
    Mol, L.
    Antonini, N. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review
    Andrew Eisenberger
    R. Lawrence Whelan
    Alfred I. Neugut
    International Journal of Colorectal Disease, 2008, 23
  • [25] Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review
    Eisenberger, Andrew
    Whelan, R. Lawrence
    Neugut, Alfred I.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (06) : 559 - 568
  • [26] The Role of Primary Tumor Resection (PTR) in Metastatic Colorectal Cancer
    Geva, Ravit
    Tulchinsky, Hagit
    CURRENT COLORECTAL CANCER REPORTS, 2015, 11 (05) : 225 - 230
  • [27] Primary tumour resection and survival in the palliative management of metastatic colorectal cancer
    Bajwa, A.
    Blunt, N.
    Vyas, S.
    Suliman, I.
    Bridgewater, J.
    Hochhauser, D.
    Ledermann, J. A.
    O'Bichere, A.
    EJSO, 2009, 35 (02): : 164 - 167
  • [28] Simultaneous Laparoscopic Resection of Colorectal Cancer and Synchronous Metastatic Liver Tumor
    Hayashi, Michihiro
    Komeda, Koji
    Inoue, Yoshihiro
    Shimizu, Tetsunosuke
    Asakuma, Mitsuhiro
    Hirokawa, Fumitoshi
    Okuda, Junji
    Tanaka, Keitaro
    Kondo, Keisaku
    Tanigawa, Nobuhiko
    INTERNATIONAL SURGERY, 2011, 96 (01) : 74 - 81
  • [29] Palliative resection of a primary tumor in patients with unresectable colorectal cancer: could resection type improve survival?
    Jang, Hyun Seok
    Ju, Jae Kyun
    Kim, Chang Hyun
    Lee, Soo Young
    Kim, Hyeong Rok
    Kim, Young Jin
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2016, 91 (04) : 172 - 177
  • [30] Mutational landscape in synchronous unresectable metastatic colorectal cancer (mCRC) according to upfront primary tumour resection (UPTR)
    Benavides, M.
    Alcaide-Garcia, J.
    Torres, E.
    Gil, S.
    Duran, G.
    Reyna, C.
    Wolman, R.
    Alvarez, M.
    Kushnir, M.
    Faull, I.
    Munoz, M.
    Alba, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S578 - S579